<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 15-year-old female with <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-pre B ALL</z:e> in third relapse was treated with administration of eight blood bank leukocyte concentrates per day for 5 days </plain></SENT>
<SENT sid="1" pm="."><plain>The total number of mononuclear cells per kilogram of weight was 4.89 x 10(8) </plain></SENT>
<SENT sid="2" pm="."><plain>On the fifth day of infusions the patient was in complete remission (CR), asymptomatic and with a <z:mpath ids='MPATH_458'>normal</z:mpath> CBC </plain></SENT>
<SENT sid="3" pm="."><plain>No secondary effects were found </plain></SENT>
<SENT sid="4" pm="."><plain>The patient remained in CR without treatment for 10 weeks before relapsing again </plain></SENT>
<SENT sid="5" pm="."><plain>The possibility of reaching a short-lived, clinically relevant response, using blood bank leukocyte infusions, is a promising new approach for the treatment of <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
</text></document>